DRRX DURECT Corporation

$2.14 -13.36%

2,059,391 Shares Traded
1,250,927 Average Volume (last 30 days)

as of April 19, 2018 EST IEX Real-Time Price

Free Newsletter Sign Up

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $513.37 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-132.56%
If Intiated One Month Ago, Shorts Have Realized a Return of:0%
If Initiated Five Days ago, Shorts Have Realized a Return of:12.3%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 1.05%
Short Interest1.56 million
Float147.99 million
Short Ratio0.97
Market Cap$328.14 million
Market Maker ActivityDaily Short Volume


U.S. opioid prescriptions down 12% last year, largest drop in 25 years (SeekingAlpha)
DEA aiming to collar production of opioids (SeekingAlpha)
Sen. Sanders introduces bill to fine opioid makers for marketing practices (SeekingAlpha)
DURECT (DRRX) Alcoholic Hepatitis Phase 2a Study - Slideshow (SeekingAlpha)
DURECT Corporation to Host Key Opinion Leader Call on Alcoholic Hepatitis (PR Newswire)
DURECT Corporation: Upcoming Milestones And DUR-928 Progress (SeekingAlpha)
DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER (PR Newswire)
Trump to release opioid epidemic plan (SeekingAlpha)
Opioid settlement talks hit roadblocks (SeekingAlpha)
Wall Street Breakfast: Markets Weighed Down By Cohn Exit (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 42.7%
Insider Percent3.5%

Earnings Stats

PE Ratio -53.5
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $1.49
50 Day Moving Average $1.81
52 Week High $2.55
52 Week Low $0.74

Data provided for free by IEX. Questions? Read the FAQ